Characterisation of recombinant glycosylation variants of insulin-like growth factor binding protein-3

被引:87
|
作者
Firth, SM [1 ]
Baxter, RC [1 ]
机构
[1] Royal N Shore Hosp, Kolling Inst Med Res, St Leonards, NSW 2065, Australia
关键词
D O I
10.1677/joe.0.1600379
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Then are three potential N-glycosylation sites in the non-conserved central region of the insulin-like growth factor binding protein-3 (IGFBP-3) sequence (N(89)AS, N(109)AS, (NFS)-F-172). IGFBP-3 exists as two glyco-forms which reduce to a single form on enzymatic deglycosylation. To determine the functional significance of the carbohydrate chains, the N-glycosylation sites were mutated singly and in combinations by substituting Asn residues with Ala. Each recombinant glycoform was detected by radioimmunoassay, indicating that glycosylation is not essential for secretion in Chinese hamster ovary cells. Ligand blotting of the conditioned media using [I-125]IGF-I indicated that all seven mutants are active. On the basis of the number and molecular masses of the: bands detected for each glycoform, there is approximately 4, 4.5 and 5 kDa of carbohydrate on Asn(89), Asn(109) and Asn(172) respectively, with variable occupancy of Asn(172). Ternary complex formation by the glycovariants in the: presence of ALS and excess IGF-I was not significantly different from that of fully glycosylated recombinant human (rh)IGFBP-3 [K-a (fully glycosylated)= 12.5 +/- 4.1 l/nmol; mean K-a (all mutants) = 22.1 +/- 3.0 l/nmol]. In contrast, Asn to Asp substitutions decreased acid-labile subunit (ALS) binding activity. Cell-surface association experiments indicate that glycosylation may influence the partitioning of IGFBP-3 between the extracellular milieu and the cell surface. Therefore, while the carbohydrate units appear to be non-essential to ALS or IGF binding, they may modulate other biological activities of IGFBP-3.
引用
收藏
页码:379 / 387
页数:9
相关论文
共 50 条
  • [1] Insulin-like growth factor binding protein-3: Insulin-like growth factor independence comes of age
    Cohen, P
    ENDOCRINOLOGY, 2006, 147 (05) : 2109 - 2111
  • [2] Transferrin is an insulin-like growth factor-binding protein-3 binding protein
    Weinzimer, SA
    Gibson, TB
    Collett-Solberg, PF
    Khare, A
    Liu, BR
    Cohen, P
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (04): : 1806 - 1813
  • [3] Nuclear actions of insulin-like growth factor binding protein-3
    Baxter, Robert C.
    GENE, 2015, 569 (01) : 7 - 13
  • [5] Insulin-Like Growth Factor Binding Protein-3 Binds to Histone 3
    Bhardwaj, Apurva
    Pathak, Kumar Alok
    Shrivastav, Anuraag
    Varma Shrivastav, Shailly
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (01) : 1 - 11
  • [6] Transferrin binds insulin-like growth factors and affects binding properties of insulin-like growth factor binding protein-3
    Storch, S
    Kübler, B
    Höning, S
    Ackmann, M
    Zapf, J
    Blum, W
    Braulke, T
    FEBS LETTERS, 2001, 509 (03) : 395 - 398
  • [7] Insulin-like growth factor binding protein-3 leads to insulin resistance in adipocytes
    Chan, SSY
    Twigg, SM
    Firth, SM
    Baxter, RC
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (12): : 6588 - 6595
  • [8] Associations of insulin-like growth factor and insulin-like growth factor binding protein-3 with mortality in women with breast cancer
    Duggan, Catherine
    Wang, Ching-Yun
    Neuhouser, Marian L.
    Xiao, Liren
    Smith, Ashley Wilder
    Reding, Kerryn W.
    Baumgartner, Richard N.
    Baumgartner, Kathy B.
    Bernstein, Leslie
    Ballard-Barbash, Rachel
    McTiernan, Anne
    INTERNATIONAL JOURNAL OF CANCER, 2013, 132 (05) : 1191 - 1200
  • [9] Insulin-Like Growth Factor-I and Insulin-Like Growth Factor Binding Protein-3 in Alzheimer's Disease
    Duron, Emmanuelle
    Funalot, Benoit
    Brunel, Nadege
    Coste, Joel
    Quinquis, Laurent
    Viollet, Cecile
    Belmin, Joel
    Jouanny, Pierre
    Pasquier, Florence
    Treluyer, Jean-Marc
    Epelbaum, Jacques
    le Bouc, Yves
    Hanon, Olivier
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (12): : 4673 - 4681
  • [10] Developmental pattern of fetal growth hormone, insulin-like growth factor I, growth hormone binding protein and insulin-like growth factor binding protein-3
    Pirazzoli, P
    Cacciari, E
    DeIasio, R
    Pittalis, MC
    Dallacasa, P
    Zucchini, S
    Gualandi, S
    Salardi, S
    David, C
    Boschi, S
    ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 1997, 77 (02): : F100 - F104